Cognitive remediation program for adults with intellectual disabilities

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the Réhabilitus cognitive remediation program designed to improve attentional and visuospatial functions in adults with intellectual disabilities. The program aims to address behavioral disorders by enhancing cognitive processing related to social situations and relationships. Participants will be adults aged 18 to 45 with mild to moderate intellectual disabilities, and the study will compare outcomes between those receiving the intervention and a control group. The program is tailored specifically for individuals without autism spectrum disorder.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 to 45 inclusive;
* Behavioral disorders corresponding to a total score on the ABC scale \> 15
* Presence of a family caregiver (parent, friend) or professional (reeducator, professional of the medico-social sector) stakeholder of the project;
* Diagnosis of mild to moderate intellectual disability (assessed by WAIS-IV battery and VABS-II less than 3 years ago;
* French or secondary mother tongue;
* Psychoactive treatment unchanged during the month prior to inclusion;
* Adult or legal representative who has given written and informed consent to participate in the study. By default, the adult's oral agreement will be collected (as well as the written consent of the legal representative);
* Affiliation to the social security scheme or beneficiary of such a scheme.

Exclusion Criteria:

* Neurological disorders of vascular, infectious or neurodegenerative origin;
* Taking medications for general medical purposes with a neurological or psychiatric impact (eg corticosteroids);
* Simultaneous participation in any other cognitive remediation program targeting attentional, visuospatial and social cognition;
* Refusal of participation of the person and/or his/her legal representative;
* Not family or professional caregiver;
* Presence of Autistic Spectrum Disorders (evaluated by ADOS and ADI if necessary according to the assessment of the investigator)

Where it's running

• Hopital Vinatier
  Lyon, Auvergne-Rhône-Alpes, France Recruiting

Study contacts

• Principal investigator: DEMILY CAROLINE, MD Ph — Centre Hospitalier le Vinatier
• Study coordinator: DEMILY CAROLINE, MD Ph
• Email: caroline.demily@ch-le-vinatier.fr
• Phone: +33437915163

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders

  This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.

  Recruiting Istituto Giannina Gaslini · Genova · NCT07884227

• Regulating Together for Emotion Dysregulation in ASD and Intellectual Disability (group therapy)

  This study tests a group therapy program for kids with autism and co-occurring intellectual disability to help them manage irritability and aggression, with sessions for both children and their caregivers.

  Recruiting Children's Mercy Hospital Kansas City · Kansas City, Missouri · NCT07624448

• Digital games to improve visual memory and thinking skills in young adults with intellectual disability

  This trial will test whether twice-weekly MentalUP digital game sessions help 18–35-year-olds with mild to moderate intellectual disability improve visual memory and cognitive skills.

  Recruiting Koç University · Istanbul, Türkiye · NCT07476092

• Using preferred communication tools to reduce challenging behavior

  This project will test whether using a person's favored communication tool (for example a touch talker or picture cards) helps keep behavior improvements and prevents relapse in people with intellectual or developmental disabilities who have little or no verbal speech.

  Recruiting at 2 sites University of Georgia · Athens, Georgia and 1 other locations · NCT07278544

• Deutetrabenazine for Tardive Dyskinesia in IDD

  This study tests whether deutetrabenazine helps reduce tardive dyskinesia in people with intellectual and developmental disabilities who have not previously received this treatment.

  Recruiting Phase 4 University Hospitals Cleveland Medical Center · Cleveland, Ohio · NCT06997198

• Theta Burst Stimulation for Emotion Regulation in Autism With Minimal Verbal Ability or Intellectual Disability

  This trial tests whether intermittent theta burst stimulation to the left prefrontal cortex can help improve emotion regulation in people with autism who are minimally verbal or have an intellectual disability.

  Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT06974838

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.